Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway
ACS Chemical Biology · 2023
DOI: 10.1021/acschembio.2c00784 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2023. Verfasst von Christopher T Saeui und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medici…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: National Cancer Institute, Florida Department of State, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
- Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida 32224, United States.
- Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States.
- Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland 21205, United States.
- Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, United States.
ORCID-Profile: Beatriz I Fernandez-Gil, Kris Dammen-Brower, Prateek Gowda, Shuang Yang, Hui Zhang, Kevin J Yarema
Förderung
- National Cancer Institute
- Florida Department of State
- National Heart, Lung, and Blood Institute
- Office of the Director
- Mayo Clinic
- University of Florida
- Florida Center for Tumor Research
- Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine
Zitieren
APA
Saeui, C. T., Shah, S. R., Fernandez-Gil, B. I., Zhang, C., Agatemor, C., Dammen-Brower, K., Mathew, M. P., Buettner, M., Gowda, P., Khare, P., Otamendi-Lopez, A., Yang, S., Zhang, H., Le, A., Quinoñes-Hinojosa, A., & Yarema, K. J. (2023). Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway. ACS Chemical Biology. https://doi.org/10.1021/acschembio.2c00784
Vancouver
Saeui CT, Shah SR, Fernandez-Gil BI, Zhang C, Agatemor C, Dammen-Brower K, et al. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway. ACS Chemical Biology. 2023. doi:10.1021/acschembio.2c00784
BibTeX
@article{Saeui2023,
author = {Saeui, Christopher T and Shah, Sagar R and Fernandez-Gil, Beatriz I and Zhang, Cissy and Agatemor, Christian and Dammen-Brower, Kris and Mathew, Mohit P and Buettner, Matthew and Gowda, Prateek and Khare, Pratik and Otamendi-Lopez, Andrea and Yang, Shuang and Zhang, Hui and Le, Anne and Quinoñes-Hinojosa, Alfredo and Yarema, Kevin J},
title = {Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway},
journal = {ACS Chemical Biology},
year = {2023},
doi = {10.1021/acschembio.2c00784}
}
EUVIMED